Watermark Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Watermark Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$3K	Hold	55	–	–	﹤0.01%	215
2018 Q3	$3K	Hold	55	–	–	﹤0.01%	191
2018 Q2	$3K	Hold	55	–	–	﹤0.01%	189
2018 Q1	$3K	Hold	55	–	–	﹤0.01%	192
2017 Q4	$3K	Hold	55	–	–	﹤0.01%	194
2017 Q3	$4K	Hold	55	–	–	﹤0.01%	185
2017 Q2	$3K	Hold	55	–	–	﹤0.01%	195
2017 Q1	$3K	Buy	+55	New	+$3.02K	﹤0.01%	193

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Watermark Asset Management's BMY Position: Q4 2018 in Review

Watermark Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q4 2018 at 55 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

Watermark Asset Management first reported a position in BMY in Q1 2017 and has held it in 8 quarters since. The position peaked at $4K in Q3 2017. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Watermark Asset Management held 55 shares of Bristol-Myers Squibb worth $3K as of Q4 2018.
Watermark Asset Management left its Bristol-Myers Squibb share count unchanged in Q4 2018.
Bristol-Myers Squibb made up ﹤0.01% of Watermark Asset Management's portfolio in Q4 2018, its #215 holding.
Watermark Asset Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 8 quarters since.
Watermark Asset Management's Bristol-Myers Squibb position peaked at $4K in Q3 2017.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.